A detailed history of Benjamin Edwards Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Benjamin Edwards Inc holds 121,996 shares of JNJ stock, worth $17.9 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
121,996
Previous 2,199 5447.79%
Holding current value
$17.9 Million
Previous $321,000 6058.88%
% of portfolio
0.29%
Previous 0.06%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$145.48 - $167.38 $17.4 Million - $20.1 Million
119,797 Added 5447.79%
121,996 $19.8 Million
Q2 2024

Aug 12, 2024

SELL
$144.38 - $157.78 $567,702 - $620,390
-3,932 Reduced 64.13%
2,199 $321,000
Q1 2024

Apr 29, 2024

SELL
$155.22 - $162.74 $260,148 - $272,752
-1,676 Reduced 21.47%
6,131 $970,000
Q4 2023

Feb 06, 2024

SELL
$145.6 - $158.88 $270,088 - $294,722
-1,855 Reduced 19.2%
7,807 $1.22 Million
Q3 2023

Nov 13, 2023

BUY
$155.75 - $174.48 $80,834 - $90,555
519 Added 5.68%
9,662 $1.51 Million
Q2 2023

Aug 15, 2023

SELL
$154.35 - $166.11 $172,408 - $185,544
-1,117 Reduced 10.89%
9,143 $1.51 Million
Q1 2023

Apr 27, 2023

SELL
$151.05 - $180.26 $547,254 - $653,081
-3,623 Reduced 26.1%
10,260 $1.59 Million
Q4 2022

Feb 07, 2023

BUY
$160.2 - $179.79 $255,679 - $286,944
1,596 Added 12.99%
13,883 $2.45 Million
Q3 2022

Oct 28, 2022

BUY
$161.33 - $179.52 $20,004 - $22,260
124 Added 1.02%
12,287 $2.01 Million
Q2 2022

Aug 12, 2022

BUY
$168.19 - $186.01 $342,939 - $379,274
2,039 Added 20.14%
12,163 $2.16 Million
Q1 2022

May 04, 2022

SELL
$158.14 - $179.59 $365,777 - $415,391
-2,313 Reduced 18.6%
10,124 $1.79 Million
Q4 2021

Feb 07, 2022

BUY
$155.93 - $173.01 $737,237 - $817,991
4,728 Added 61.33%
12,437 $2.13 Million
Q3 2021

Nov 02, 2021

BUY
$161.5 - $179.47 $126,293 - $140,345
782 Added 11.29%
7,709 $1.25 Million
Q2 2021

Aug 11, 2021

SELL
$159.48 - $171.07 $2,551 - $2,737
-16 Reduced 0.23%
6,927 $1.14 Million
Q1 2021

May 14, 2021

BUY
$153.07 - $170.48 $44,084 - $49,098
288 Added 4.33%
6,943 $1.14 Million
Q4 2020

Feb 16, 2021

SELL
$137.11 - $157.38 $333,725 - $383,062
-2,434 Reduced 26.78%
6,655 $1.05 Million
Q3 2020

Nov 16, 2020

SELL
$140.38 - $153.83 $12,213 - $13,383
-87 Reduced 0.95%
9,089 $1.35 Million
Q2 2020

Aug 14, 2020

BUY
$128.81 - $155.51 $178,144 - $215,070
1,383 Added 17.75%
9,176 $1.29 Million
Q1 2020

May 07, 2020

BUY
$111.14 - $153.99 $684,400 - $948,270
6,158 Added 376.64%
7,793 $1.02 Million
Q4 2019

Feb 06, 2020

BUY
$127.5 - $146.44 $14,152 - $16,254
111 Added 7.28%
1,635 $238,000
Q3 2019

Nov 05, 2019

SELL
$126.95 - $142.14 $331,085 - $370,701
-2,608 Reduced 63.12%
1,524 $197,000
Q2 2019

Aug 08, 2019

BUY
$131.15 - $144.24 $277,251 - $304,923
2,114 Added 104.76%
4,132 $575,000
Q1 2019

May 15, 2019

BUY
$125.72 - $139.79 $253,702 - $282,096
2,018 New
2,018 $282,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $383B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Benjamin Edwards Inc Portfolio

Follow Benjamin Edwards Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benjamin Edwards Inc with notifications on news.